Phase I/II dose expansion of a trial investigating bendamustine and pomalidomide with dexamethasone (BPd) in patients with relapsed/refractory multiple myeloma.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sivaraj, D; Green, MM; Kang, Y; Rizzieri, D; Diehl, LF; Beaven, AW; Li, Z; Garrett, A; McIntyre, J; Long, GD; Chao, NJA; Gasparetto, C

Published Date

  • May 20, 2017

Published In

Volume / Issue

  • 35 / 15_suppl

Start / End Page

  • 8008 - 8008

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2017.35.15_suppl.8008